Please assess the completion status of the following clinical trial:

Trial Title: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with acute coronary disease with clinical symptoms and at least electrocardiogram changes or cardiac enzymes elevated~Exclusion Criteria:~* Use of anticoagulants within 10 days with an international normalized ratio (INR) \> 1.5 or planned use during the hospitalisation period~* Administration of clopidogrel \> 75 mg prior to randomization~* Contraindication to clopidogrel or aspirin~* Active bleeding or significant risk of bleeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clopidogrel high dose treatment regimen + ASA high dose (Type: EXPERIMENTAL): None
- Clopidogrel high dose treatment regimen + ASA low dose (Type: EXPERIMENTAL): None
- Clopidogrel standard treatment regimen + ASA high dose (Type: ACTIVE_COMPARATOR): None
- Clopidogrel standard treatment regimen + ASA low dose (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).